High-power 532nm laser prostatectomy: An update

Current Opinion in Urology

Volumn 20, Issue 1, 2010, Pages 13-19

  Chung, Doreen E ^a   Te, Alexis E ^b  

^a Memorial Sloan Kettering Cancer Center ^*  (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Benign prostatic hyperplasia; Laser; Transurethral resection of prostate

Indexed keywords

COLLIMATOR; COMORBIDITY; ENUCLEATION; FOLLOW UP; HIGH RISK PATIENT; HOLMIUM LASER; HUMAN; INSTRUMENTATION; INTERMETHOD COMPARISON; LASER; LASER PROSTATECTOMY; NEODYMIUM LASER; NONHUMAN; OUTCOME ASSESSMENT; POTASSIUM TITANYL PHOSPHATE LASER; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REVIEW; SAFETY; SURGICAL TECHNIQUE; THERAPY EFFECT; TRANSURETHRAL RESECTION; TREATMENT INDICATION; VAPORIZATION; COMPARATIVE STUDY; LOW LEVEL LASER THERAPY; MALE; METHODOLOGY;

HUMANS; LASER THERAPY; MALE; PROSTATIC HYPERPLASIA; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 74549184991     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e3283336f58     Document Type: Review

References (37)

1. Kollmorgen T, Malek R, Barrett D. Laser prostatectomy: two and a half years' experience with aggressive multifocal therapy. Urology 1996; 48:217-222.
2. Kuntzman R, Malek R, Barret D, Bstowick D. Potassium-titanyl-phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines. Urology 1996; 48:575-583.
3. Kuntzman R, Malek R, Barrett D, Bostwick D. High-power (60-watt) potassium- titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. Urology 1997; 49:703-708.
4. Malek R, Barrett D, Kuntzman R. High power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 h later. Urology 1998; 51:254-256.
5. Malek R, Kuntzman R, Barrett D. High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol 2000; 163:1730-1733.
6. Reich O, Bachmann A, Schneede P, et al. Experimental comparison of high power (80W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol 2004; 171:2502-2504.
7. Hai M, Malek R. Photoselective vaporization of the prostate: initial experience with a new 80W KTP laser of the treatment of benign prostatic hyperplasia. J Endourol 2003; 17:93-96.
8. Te A, Malloy T, Stein B, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 2004; 172:1404-1408.
9. Ruszat R, Seitz M, Wyler S, et al. Greenlight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 2008; 54:893-901.
10. Te A, Malloy T, Stein B, et al. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 2006; 97:1229-1233.
11. Hai M. Photoselective vaporization of the prostate: five-year outcomes of entire clinic population. Urology 2009; 73:807-810.
12. Te A. The next generation in laser treatments and the role of the GreenLight high-performance system laser. Rev Urol 2008; 8:S24-S30.
13. Lee R, Saini R, Zoltan E, Te A. Photoselective vaporization of the prostate using a laser high performance system in the canine model. J Urol 2008; 180:1550-1553.
14. Kang H, Jebens D, Malek R, et al. Laser vaporization of bovine prostate: a quantitative comparison of potassium-titanyl-phosphate and lithium triborate lasers. J Urol 2008; 180:2675-2680.
15. Malek R, Kang H, Coad J, Koullick E. Greenlight photoselective 120-watt 532- nm lithium triborate laser vaporization prostatectomy in living canines. J Endourol 2009; 23:837-845.
16. Malek R, Barrett D, Kuntzman R. High-power potassium-titanyl-phosphate (KTP1/4532) laser vaporization prostatectomy: 24 h later. Urology 1998; 51:254-256. (Pubitemid 28093177)
17. Woo H, Reich O, Bachmann A, et al. Outcome of GreenLight HPS 120-W laser therapy in specific patient populations: those in retention, on anticoagulants, and with large prostates (-80 ml). Eur Urol Suppl 2008; 7:378-383.
18. Spaliviero M, Araki M, Culkin D, Wong C. Incidence, management, and prevention of perioperative complications of GreenLight HPS laser photoselective vaporization prostatectomy: experience in the first 70 patients. J Endourol 2009; 23:495-502.
19. Sandhu J, Ng C, VanderBrink B, et al. High power potassium- titanylphosphate (KTP) photoselective laser vaporization of the prostate (PVP) for the treatment of benign prostatic hyperplasia (BPH) in men with large prostates. Urology 2004; 64:1155-1159.
20. Nomura H, Seki N, Yamaguchi A, Naito S. Photoselective vaporization of the prostate: outcome according to the prostate size in a series of 102 Japanese patients. In J Urol 2009; 16:87-90.
21. Skolarikos A, Papachristou C, Athanasiadis G, et al. Eighteen-month results of a randomized prospective study comparing transurethral photoselective vaporization with transvesical open enucleation for prostatic adenomas greater the 80 cc. J Endourol 2008; 22:2333-2340.
22. Pfitzenmaier JG, Pritsch M, Herrmann D, et al. Vaporization of prostates of > or 1/4 80mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80mL. BJU Int. 2008; 102: 322-327.
23. Horasanli K, Silay M, Altay B, et al. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short term randomized prospective study. Urology 2008; 71:247-251.
24. Rajbabu K, Chandrasekara S, Barber N, et al. Photoselective vaporization of the prostate with the potassium-titanyl-phosphate laser in men with prostates of >100 mL. BJU Int 2007; 100:593-598.
25. Reich O, Bachmann A, Siebels M, et al. High power (80W) potassium-titanylphosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005; 173:158-160.
26. Sandhu J, Ng C, Gonzalez R, et al. Photoselective laser vaporization prostatectomy in anticoagulated men. J Endourol 2005; 19:1196-1198.
27. Descazeaud A, Robert G, Azzousi A, et al. Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review. BJU Int 2009; 103:1162-1165.
28. Fateri F, Schwartz J, Saaidia A, et al. KTP-80 laser endovaporisation of prostate symptomatic hypertrophy in patients under anticoagulant and/or antiagregant therapy. Rev Med Suisse 2007; 3:2794-2797.
29. Hori Y, Kuromatsu I, Sugimura Y. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients with oral anticoagulant therapy. Hinyokika Kiyo 2008; 54:651-656.
30. Ruszat R, Wyler S, Seitz M, et al. Comparison of potassium-titanyl- phsphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective nonrandomized two-centre study. BJU Int 2008; 102:1432-1438.
31. Nomura H, Seki N, Yamaguchi A, Naito S. Comparison of photoselective vaporization and standard transurethral resection of the prostate on urodynamics in patients with benign prostatic hyperplasia. Int J Urol 2009; 16:657-662.
32. Bouchier-Hayes D, Anderson P, Van Appledorn S, et al. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 2006; 20:580-585.
33. Bachmann A, Schurch L, Ruszat R, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005; 48:956-972.
34. Seki N, Nomura H, Yamaguchi A, Naito S. Evaluation of the learning curve for photoselective vaporization of the prostate over the course of 74 cases. J Endourol 2008; 22:1731-1735.
35. Tan A, Gilling P. Holmium laser prostatectomy: current techniques. Urology 2002; 60:152-156.
36. Gilling P, Aho T, Frampton C, et al. Holmium laser enucleation of the prostate: results at 6 years. Eur Urol 2008; 53:744-749. (Pubitemid 351273870)
37. Chung D, Lee R, Te A. Transurethral laser enucleation of the prostate (TLEP): 2-year experience [abstract]. J Urol 2009; 184 (Suppl 1):130.